Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROSPECTIVE RANDOMISED EVALUATION OF HIGH-INTENSITY CHEMOTHERAPY WITH PERIPHERAL BLOOD PROGENITOR SUPPORT IN PATIENTS WITH HIGH RISK BREAST CANCER

NCT00002755 is registered in ClinicalTrials.gov with Scottish Cancer Therapy Network as lead sponsor.

NCT NCT00002755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROSPECTIVE RANDOMISED EVALUATION OF HIGH-INTENSITY CHEMOTHERAPY WITH PERIPHERAL BLOOD PROGENITOR SUPPORT IN PATIENTS WITH HIGH RISK BREAST CANCER
Lead sponsor
Scottish Cancer Therapy Network
Phase
Phase 3
Overall status
Completed
Start date
November 30, 1995
Completion date
June 30, 1999
Enrollment
600 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer